
Ericure Remedies Private Limited
About Ericure Remedies Private Limited
Data last updated:
Ericure Remedies Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC305057. Its GSTIN is 27AAECE9317R1ZX (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajit Anil Mane and Vijay Dinkar Mohite.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹28,384 (net margin 0.2%) and EBITDA of ₹1.59 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ericure Remedies Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA4 26A Narayan Plaza Off. Saki Vihar Road Chandivali Kurla Chandivali Near Kamani, Oil Mill, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ericure Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ericure Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ericure Remedies Private Limited, buy the company report.
Financials of Ericure Remedies Private Limited
FY 2025 filings availableEricure Remedies Private Limited reported revenue of ₹1.25 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,384 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ericure Remedies Private Limited, buy the company report.
Board of directors of Ericure Remedies Private Limited
Ericure Remedies has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Anil Mane | Director | 13 Feb 2018 | 8 Years 8 Months | Current |
| Vijay Dinkar Mohite Also directs: Parshvanath Tradezone LLP, Vibrieri Healthcare LLP | Director | 13 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Ericure Remedies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Standard Financial Consultants Private Limited | ₹1.25 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Sanwadia Industries Private Limited | ₹1.25 Cr (FY 2025) | -12.0% | Jaipur, Rajasthan, India | |||
| Zoydec Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 19.0% | Chandigarh, India | |||
| Sany Cons Pvt Ltd | ₹1.25 Cr (FY 2025) | -6.0% | Kolkata, West Bengal, India | |||
| CLF Transtrade India Private Limited | ₹1.25 Cr (FY 2025) | 98.0% | Ahmedabad, Gujarat, India | |||
| Ericure Remedies Private Limitedthis company | ₹1.25 Cr (FY 2025) | ₹28,384 | 0.2% | -7.0% | Mumbai, Maharashtra, India | |
| Abhinandan Creations Private Limited | ₹1.25 Cr (FY 2025) | -18.0% | New Delhi, Delhi, India | |||
| Dhanganga Distributors Private Limited | ₹1.25 Cr (FY 2024) | -40.0% | Kolkata, West Bengal, India | |||
| VKMG Enterprises Private Limited | ₹1.25 Cr (FY 2024) | -27.0% | New Delhi, Delhi, India | |||
| Healthtree Pharma (India) Private Limited | ₹1.25 Cr (FY 2025) | -58.0% | Chandigarh, India | |||
| Tuhin Chemicals Agency Pvt Ltd | ₹1.25 Cr (FY 2022) | 76.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Ericure Remedies Private Limited, buy the company report.
Auditor
Ericure Remedies Private Limited is audited by ARVIND BANSAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARVIND BANSAL & CO | FY 2021 | 100573W |
Shareholding
The shareholding of Ericure Remedies Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ericure Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ericure Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ericure Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ericure Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE9317R1ZX | Maharashtra | Active | 13 Apr 2018 |
To see the full GST registrations and return filing status of Ericure Remedies Private Limited, buy the company report.
Recent activity
Ericure Remedies Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Amit Ashok Suryavanshi ceased to be Director on 03 Oct 2024.
Frequently asked questions
Ericure Remedies is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305057.
Ericure Remedies has 2 current directors:
- Ajit Anil Mane - Director
- Vijay Dinkar Mohite - Director
The latest financial statements of Ericure Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ericure Remedies is 27AAECE9317R1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ericure Remedies is U74999MH2018PTC305057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ericure Remedies was incorporated on 13 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ericure Remedies by revenue are Standard Financial Consultants Private Limited, Sanwadia Industries Private Limited, Zoydec Pharmaceuticals Private Limited, Sany Cons Pvt Ltd, CLF Transtrade India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Amit Ashok Suryavanshi ceased to be Director on 03 Oct 2024. Rahul Kunhiraman Poduval ceased to be Additional Director on 30 Nov 2021. Radheshyam Suryanarayan Thakur ceased to be Director on 10 Aug 2021. Ericure Remedies has 7 board changes on record in total.
The registered office of Ericure Remedies is at A4 26A Narayan Plaza Off. Saki Vihar Road Chandivali Kurla Chandivali Near Kamani, Oil Mill, Mumbai, Maharashtra, India – 400058.
Ericure Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ericure Remedies is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.

